These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 29759552)
41. LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition. Han Y; Ye J; Wu D; Wu P; Chen Z; Chen J; Gao S; Huang J BMC Cancer; 2014 Dec; 14():932. PubMed ID: 25496320 [TBL] [Abstract][Full Text] [Related]
42. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma. Qiu L; Tang Q; Li G; Chen K Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633 [TBL] [Abstract][Full Text] [Related]
43. The expression of long non-coding RNA LINC01389, LINC00365, RP11-138J23.1, and RP11-354K4.2 in gastric cancer and their impacts on EMT. Taghehchian N; Farshchian M; Mahmoudian RA; Asoodeh A; Abbaszadegan MR Mol Cell Probes; 2022 Dec; 66():101869. PubMed ID: 36208698 [TBL] [Abstract][Full Text] [Related]
44. PANDAR: a pivotal cancer-related long non-coding RNA in human cancers. Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X Mol Biosyst; 2017 Oct; 13(11):2195-2201. PubMed ID: 28976505 [TBL] [Abstract][Full Text] [Related]
45. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression. Huang R; Zong X Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165 [TBL] [Abstract][Full Text] [Related]
46. Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition. Liu H; Lv Z; Guo E Int J Clin Exp Pathol; 2015; 8(8):9140-6. PubMed ID: 26464658 [TBL] [Abstract][Full Text] [Related]
47. Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals. Rathinasamy B; Velmurugan BK Biomed Pharmacother; 2018 Jun; 102():242-248. PubMed ID: 29567536 [TBL] [Abstract][Full Text] [Related]
48. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Zhao Y; Guo Q; Chen J; Hu J; Wang S; Sun Y Oncol Rep; 2014 Jan; 31(1):358-64. PubMed ID: 24247585 [TBL] [Abstract][Full Text] [Related]
49. Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment. Ho KH; Huang TW; Shih CM; Lee YT; Liu AJ; Chen PH; Chen KC BMC Med; 2021 Feb; 19(1):59. PubMed ID: 33627136 [TBL] [Abstract][Full Text] [Related]
50. Roles and Mechanisms of Long Non-Coding RNAs in Breast Cancer. Su J; Deng L; Wang YD Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613528 [TBL] [Abstract][Full Text] [Related]
51. The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers. Pan Y; Li C; Chen J; Zhang K; Chu X; Wang R; Chen L Cell Physiol Biochem; 2016; 40(1-2):219-229. PubMed ID: 27855392 [TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance. Hashemi M; Hajimazdarany S; Mohan CD; Mohammadi M; Rezaei S; Olyaee Y; Goldoost Y; Ghorbani A; Mirmazloomi SR; Gholinia N; Kakavand A; Salimimoghadam S; Ertas YN; Rangappa KS; Taheriazam A; Entezari M Pharmacol Res; 2022 Dec; 186():106535. PubMed ID: 36334877 [TBL] [Abstract][Full Text] [Related]
53. Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy. Ashrafizadeh M; Shahinozzaman M; Orouei S; Zarrin V; Hushmandi K; Hashemi F; Kumar A; Samarghandian S; Najafi M; Zarrabi A Curr Cancer Drug Targets; 2021; 21(8):640-665. PubMed ID: 33535952 [TBL] [Abstract][Full Text] [Related]
55. New twists on long noncoding RNAs: from mobile elements to motile cancer cells. Nguyen TM; Alchalabi S; Oluwatoyosi A; Ropri AS; Herschkowitz JI; Rosen JM RNA Biol; 2020 Nov; 17(11):1535-1549. PubMed ID: 32522127 [TBL] [Abstract][Full Text] [Related]
56. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability. Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236 [TBL] [Abstract][Full Text] [Related]
57. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
58. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961 [TBL] [Abstract][Full Text] [Related]
59. The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment. Guo Y; Xie Y; Luo Y Front Immunol; 2022; 13():851004. PubMed ID: 35222443 [TBL] [Abstract][Full Text] [Related]
60. Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development. Dalla Pozza E; Forciniti S; Palmieri M; Dando I Semin Cell Dev Biol; 2018 Jun; 78():62-72. PubMed ID: 28673679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]